Old Web
English
Sign In
Acemap
>
Paper
>
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
2021
Rohit Loomba
Vlad Ratziu
Stephen A. Harrison
Stefanie C McFarlane
Nobuharu Tamaki
Manal F. Abdelmalek
Mary E. Rinella
Quentin M. Anstee
Zobair M. Younossi
Arun J. Sanyal
Vipul Jairath
Keywords:
Intensive care medicine
nonalcoholic steatohepatitis
Clinical trial
Drug development
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]